News & Media

Latest News

Filter Your Search

Ibrutinib Outperforms Chemoimmunotherapy in Older Patients with Chronic Lymphocytic Leukemia

Results from an multi-institutional, phase 3 clinical trial show that older patients with chronic lymphocytic leukemia (CLL) have a significantly lower rate of disease progression if treated with the newer targeted drug, ibrutinib, rather than bendamustine plus rituximab—the regimen previously considered as one of the most effective therapies in this group of patients. Read More

Results from an multi-institutional, phase 3 clinical trial show that older patients with chronic lymphocytic leukemia (CLL) have a significantly lower rate of disease progression if treated with the newer targeted drug, ibrutinib, rather than bendamustine plus rituximab—the regimen previously considered as one of the most effective therapies in this group of patients. Read More

At-Home HPV Tests Could Be Powerful Tool for Hard-to-Reach U.S. Women

Screening women for HPV, or human papillomavirus, is a promising way to help detect cervical cancer early, but many at-risk women go without screening for the virus and without Pap tests that look for abnormal cells on the cervix. Read More

Screening women for HPV, or human papillomavirus, is a promising way to help detect cervical cancer early, but many at-risk women go without screening for the virus and without Pap tests that look for abnormal cells on the cervix. Read More

Region's First Proton Therapy Facility to Treat Cancer Patients

The Ohio State University Wexner Medical Center and The James are collaborating with Nationwide Children’s Hospital to bring the first proton therapy treatment facility to central Ohio. This will offer state-of-the-art radiation oncology treatment for adult and pediatric cancer patients in one place. Read More

The Ohio State University Wexner Medical Center and The James are collaborating with Nationwide Children’s Hospital to bring the first proton therapy treatment facility to central Ohio. This will offer state-of-the-art radiation oncology treatment for adult and pediatric cancer patients in one place. Read More

Find an Expert

See All Experts

Search Our Media Library

See All Images

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).